Inovio Pharma (INO) Misses Q2 EPS by 14c
Tweet
Share
E-mailGet Alerts INO Hot Sheet
Price: $1.15 --0%
Financial Fact:
Loss from operations: -20.2M
Today's EPS Names:
HSAI, SYRS, EGRX, More
Financial Fact:
Loss from operations: -20.2M
Today's EPS Names:
HSAI, SYRS, EGRX, More
Join SI Premium – FREE
Inovio Pharma (NASDAQ: INO) reported Q2 EPS of ($0.39), $0.14 worse than the analyst estimate of ($0.25). Revenue for the quarter came in at $273 thousand versus the consensus estimate of $1.21 million.
For earnings history and earnings-related data on Inovio Pharma (INO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Norwegian Cruise Line Holdings (NYSE: NCLH) PT Raised to $20 at UBS
- Baidu (BIDU) Misses Q2 EPS by 262c, misses on revenue
- Evogene (EVGN) Tops Q2 EPS by 15c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
